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Four organotin(IV) complexes with 2-(2-hydroxybenzylideneamino)isoindoline-1,3-dione (L1), and 4-(4-hydroxy-3-methoxy-
benzylideneamino-N-(pyrimidin-2-yl)benzenesulfonamide(L2)weresynthesizedandwellcharacterizedbyanalyticalandspectral
studies. The synthesized compounds were tested for antimicrobial activity by disc diﬀusion method. The DNA binding of the
complexes 1 and 3 with CT-DNA has been performed with absorption spectroscopy, which showed that both the complexes are
avid binders of CT-DNA. Also the nuclease activity of complexes 1 and 3 with plasmid DNA (pUC19) was studied using agarose
gel electrophoresis. The complex 1 can act as eﬀective DNA cleaving agent when compared to complex 3 resulting in the nicked
form of DNA under physiological conditions. The gel was run both in the absence and presence of the oxidizing agent.
1.Introduction
Organotin(IV) complexes have been the subject of interest
for some time because of their biomedical and commercial
applications [1]. It has been observed that several organotin
complexes are eﬀective antifouling, antimicrobial [2], and
antiviral agents. The booming application of metal com-
plexes in the treatment of numerous human diseases is
a vigorously expanding area in biomedical and inorganic
chemistry [3, 4]. The variation in coordination number,
geometries, accessible redox states, thermodynamic, and
kinetic characteristics and the intrinsic properties of the
metal ion are some special characteristics of organometallic
complexes that oﬀer the medicinal chemists to employ
diﬀerent strategies for their exploitation.
Their use in cancer chemotherapy is gaining mounting
importance. Complexes of platinum(II) like cisplatin, oxali-
platin, nedaplatin, and carboplatin have achieved clinical
status as a result of intensive research focused on anticancer
metal based drugs. However, in spite of having reasonable
therapeutic index, the applications of metal complexes
are limited by serious disadvantages like (a) poor water
solubility and (b) toxicity towards the healthy cells. So the
synthesis of nonplatinum chemotherapeutics with positive,
no or limited side eﬀects is considered reasonable. Due to the
potential antibacterial, antifungal, and anticancer activity,
organotins are the subject of intensive investigations [5–
8]. In addition to their anti-tumor activities, organotin(IV)
complexes with Schiﬀ bases present an interesting variety
of structural possibilities [9]. Increasing attention has also
been devoted to the organotin(IV) complexes with Schiﬀ
base ligands in view of their special anti-tumor activities
[10–12].
However, in spite of such an importance the number of
reportsavailableonorganotin(IV)complexesandtheirDNA
binding properties is very few. As an extension of the studies
of organotin(IV) complexes with Schiﬀ bases [13, 14], we
have now synthesized four organotin(IV) complexes with2 Bioinorganic Chemistry and Applications
Schiﬀ bases, 2-(2-hydroxybenzylideneamino)isoindoline-
1,3-dione, and 4-(4-hydroxy-3-methoxybenzylideneamino-
N-(pyrimidin-2-yl) benzenesulfonamide.
Furthermore, their DNA binding properties and cleavage
studies were performed. The objective of the current study
is to provide useful insights in the understanding of drug-
DNA interaction mechanism and antimicrobial potency of
prepared organotin(IV) complexes.
2. Experimental
2.1. Materials and Reagents. All the chemicals used were of
analytical grade and were used without further puriﬁcation.
CT-DNA and pUC19 plasmid DNA were purchased from
Sigma. Elemental analyses (carbon, hydrogen, nitrogen,
oxygen and sulphur) were performed using a Perkin-Elmer
240 elemental analyzer. IR spectra of the Schiﬀ base ligands
and their complexes were recorded on a Shimadzu FT-IR-
8300 instrument using KBr discs in the range of 4000–
200cm−1. 1H-NMR spectra of the synthesized compounds
were recorded on Bruker DRX-300 spectrometer using
DMSO-d6 as solvent and TMS as the internal standard.
Molar conductivity measurements were recorded on a CM-
82T Elico conductivity bridge in DMSO. Thermogravimetric
analyses data were measured from room temperature to
700◦C at a heating rate of 20◦C/min. The data were recorded
on a Shimadzu TG-50 thermobalance. Absorption spectra
were recorded using a hp spectrophotometer (Agilent 8453).
2.2. Synthesis of Ligands. The condensation of N-ami-
nophthalimide or sulfadiazine with salicylaldehyde was
done in methanol (L1)a n dT H F( L 2). A solution of N-
aminophthalimide(0.3221g,2mmol)in15cm3 ofmethanol
or a solution of sulfadiazine (0.500g, 2mmol) in 15cm3 of
THF was added slowly with constant stirring to a solution
of salicylaldehyde (2mmol) and the reaction mixture was
reﬂuxedfor4hs(Scheme 1).Thecolorlessproductsobtained
were ﬁltered, washed with hot water and dried in air. The
products were crystallized from ethanol.
2.3. Synthesis of Organotin(IV) Complexes. A methano-
lic solution (15cm3) of the above prepared two ligands
(1mmol) was allowed separately to react with a methanolic
solution of dimethyltin(IV)dichloride (0.221g, 1mmol)
species in 1:1 and 1:1: 1 using methanolic solution of
1,10-phenanthroline (0.198g, 1mmol) as another bidentate
ligand. The reaction mixture was stirred continuously for 1h
and reﬂuxed for 3h, respectively, for the preparation of 1:1
and 1:1: 1 complexes. The precipitate obtained was ﬁltered,
washed with hot methanol, and dried in air.
2.4.AntimicrobialActivity. Theinvitroantimicrobialscreen-
ing eﬀects of the synthesized ligands and their corresponding
organotin complexes were evaluated against ﬁve bacterial
strains, namely, Bacillus subtilis, E. coli, Staphylococcus
aureus,Ralstoniasolanacearum,andXanthomonasvesicatoria
bypaperdiscdiﬀusionmethod,usingnutrientagarmedium.
The antifungal activities of the compounds were evaluated
against Aspergillus niger, Aspergillus ﬂavus, Fusarium oxyspo-
rum and Alternaria solani by disc diﬀusion technique using
potato dextrose agar as medium [15, 16]. All the tests were
performed in triplicate, and average is reported.
2.5. DNA Binding Studies. The DNA concentration per
nucleotide was determined adopting absorption spec-
troscopy using the known molar extinction coeﬃcient value
of6600M−1 cm−1 at260nm[17].Absorptiontitrationswere
performed by using a ﬁxed metal complex concentration to
which increments of the DNA stock solution were added.
Metal complex DNA solutions were incubated for 10min
before the absorption spectra were recorded.
2.6. Viscosity Measurements. Viscosity measurements were
carried out using an Ubbelodhe viscometer at room tem-
perature. The viscometric studies were carried out in buﬀer
solution (pH 7.2). Flow time was measured by hand with
digital stopwatch, each sample was measured three times,
and the average ﬂow time was calculated. The data were
reported as (η/ηo)1/3 versus the binding ratio [18], where η
is the viscosity of DNA in the presence of the compound
and ηo is the viscosity of DNA solution alone. Viscosity
values were calculated from the observed ﬂow time of DNA
containing solution corrected for the ﬂow time of the buﬀer
alone.
2.7. Photonuclease Activity. The gel electrophoresis experi-
ments using supercoiled pUC19 DNA were carried out as
reported previously [19, 20]. The extent of cleavage was
measured from the intensities of the bands using the Alpha
Innotech Gel documentation system (AlphaImager 2200).
For mechanistic investigation, reactions were carried out by
addingradicalscavengingagents(H2O2)tosupercoiledDNA
prior to the addition of the complex before incubation.
3. Results and Discussion
All the metal complexes are air stable and decompose at
higher temperature (>300◦C). The complexes are insoluble
in water, ethanol, and methanol but soluble in DMF and
DMSO. The analytical data along with some physical prop-
erties of the ligands and their metal complexes are reported
in Table 1. The molar conductivity values of complexes in
DMSO are in the range of 4.25–9.22Scm2 mol−1 indicating
their nonelectrolytic nature [21].
4.InfraredSpectra
The IR spectra of the free ligands were compared with the
spectra of the organotin(IV) complexes in order to study the
binding mode of Schiﬀ bases to organotin(IV) in the new
complexes. Several signiﬁcant changes with respect to the
ligands are observed in the corresponding diorganotin(IV)
complexes, which are listed in Table 2. A sharp band at
1725cm−1 in L1 is due to ν(C=O) is completely merged in
complex 1indicatingthechelationoftheligandmoietytotin
with the oxygen atom and in complex 2 it is found to be atBioinorganic Chemistry and Applications 3
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Scheme 1: Synthetic route of the ligands.
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Figure 1: (a) Thermogravimetric (TGA) curve of organotin(IV) complexes (1–4) and (b) DSC curve of ligand (L1)a n dc o m p l e x e s( 1 and
2).
Table 1: Analytical data and some physical properties of the Schiﬀ base ligands and their organotin(IV) complexes.
Compound Mol. formula Yield%
ωi (calc.)/% Molar conductivity Scm2 mol−1
ωi (found)/%
CH SO N
L1 C15H10N2O3 84 67.41 (67.60) 3.72 (3.75) — 17.88 (18.02) 10.32 (10.51) —
1 C17H15N2O3Sn 67 49.09 (49.32) 3.51 (3.65) — 11.42 (11.59) 6.66 (6.76) 9.20
2 C29H23N4O3Sn 73 58.52 (58.61) 3.78 (3.90) — 7.82 (8.02) 9.31 (9.42) 4.25
L2 C18H16N4O4S 82 55.91 (56.24) 4.01 (4.20) 8.19 (8.34) 16.3 (16.65) 14.41 (1457) —
3 C38H34N8O8S2Sn 57 49.86 (49.95) 3.61 (3.75) 6.91 (7.01) 13.87 (14.01) 12.09 (12.26) 5.62
4 C32H30N6O4SSn 62 52.11 (53.87) 4.91 (4.23) 4.28 (4.49) 8.66 (8.97) 11.61 (11.78) 8.934 Bioinorganic Chemistry and Applications
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Figure 2: Structures of ligands and organotin(IV) complexes [M=Sn(IV)].
M 12 3456
(a)
M123456
Form II
Form III
Form I
(b)
Figure 3: Cleavage of supercoiled pUC19 DNA (0.5μg) by the ligands and complexes (a) 1and (b) 3in a buﬀer containing 50mM Tris-HCl
at 37◦C (30min). lane M: marker; lane 1: DNA control; lane 2: L1 (10−3 M )+D N A ;l a n e3 :D N A+H 2O2;l a n e4 :L 2 +D N A+H 2O2;l a n e5 :
complex (10−3 M )+D N A ;l a n e6 :c o m p l e x+D N A+H 2O2.Bioinorganic Chemistry and Applications 5
the same position suggesting the noninvolvement of the
carbonyl group of L1 with the central atom. The IR band
of another carbonyl group is slightly aﬀected by bending
and because of this bending the band at 1768cm−1 due to
ν(C=O) in L1 decreased to 1676cm−1 in complex 1 and to
1650cm−1 in complex 2. A sharp band at 3384cm−1 in L1
due to ν(–OH) is found to be disappearing in both the com-
plexes 1 and 2, indicating the deprotonated phenolic oxygen
donor site to the tin atom. It was also found that the band
at 1618cm−1 in L1 due to ν(C=N) is absent in the complex
1 and it was slightly shifted to 1617cm−1 in the complex 2
indicating the involvement of N-atom of azomethine group
in the coordination with the tin. Comparing the IR spectra
of L2 with those of complex of 3 and 4 gave important
information. A characteristic band at 1652cm−1 in L2 due
to ν(C=N) is found to be disappearing in the complex 3,
and it was shifted to 1658cm−1 in complex 4 indicating
the chelation of the N-atom of the ligand moiety to the
tin atom. The band at 3423cm−1 due to ν(–OH) is found
to be disappearing in the case of complex 3 indicating the
chelation of oxygen atom to the tin. In the complex 4, it
is found unchanged indicating the noninvolvement of the
phenolic oxygen in the chelation with the central tin atom.
The characteristic band at 941cm−1 in L2 due to ν(–N–SO2)
isshiftedto891cm−1 inthecomplex3indicatingtheinvolve-
ment of N-atom in the complexation, and it was found that
the peak position was unchanged in case of complex 4 indi-
cating the non-involvement of N-atom in the coordination
process. Similarly, the band at 2360cm−1 due to ν(–NH) is
shifted to 2399cm−1 in the complex 3 indicating that the
N-atom is involved in coordination with tin atom and also
suggesting the structure of complex 3 polymeric in nature,
and it was found that the peak was remained in the same
position indicating that the N-atom is not involved in the
coordination.
5. 1H-NMR Spectra
The bonding pattern is further supported by 1H-NMR
spectral studies of ligands and their corresponding tin
complexes. The signal at 9.45ppm in L1 and at 9.77ppm
in L2 is assigned to azomethine (HC=N) proton, which was
shifted to down ﬁeld in the spectra of all the complexes;
this is attributed to the donation of the lone pair of
electrons by the azomethine nitrogen to the tin atom. The
–OH proton signal in L1 at 10.67ppm was found to be
shifted to 10.63–10.65ppm indicating the involvement of
phenolic oxygen in the coordination in complexes 1 and
2.I nL 2 the –OH signal was at 10.26ppm and is shifted
to 10.28ppm in the complex 3 and remained unchanged
in complex 4, indicating that the oxygen atom is involved
in the chelation with the central tin atom in complex
3.T h e1H-NMR spectra of ligands in DMSO-d6 revealed
a multiplet at 6.01–7.95ppm corresponding to aromatic
protons [22]. All the complexes show signal around 1.00–
1.03ppm, which corresponds to Sn–CH3 group. 1H-NMR
data of ligands and their complexes are presented in
Table 3.
6.ElectronicSpectra
Electronic spectra of the ligands and their metal complexes
were recorded in DMF. An absorption band found at 351nm
in L1 is due to n → π∗ transition, and was decreased
in its complex 1 to 344nm having n → π∗ transition,
and complex 2 has another band found at 384nm, having
ligand ﬁeld transition. A band at 340nm in L2 has been
found at 340nm in complex 3 having n → π∗ transition
and at 380nm in complex 4 having ligand ﬁeld transition.
The spectra of the complexes are dominated by intense
intraligand and charge transfer bands, since it is known that
metal/metalloids are capable of forming dπ-pπ bonds with
ligands containing nitrogen and oxygen as donor atoms [23].
7. Thermal Studies
The thermal analysis of the ligand (L1) and all the synthe-
sized organotin(IV) complexes was carried out under an
inert atmosphere (N2). The ligand (L1) exhibits one-step
thermolytic pattern while all the complexes decompose in
three stages (Figures 1(a) and 1(b)). The decomposition
of the free ligand begins at 156◦C and exhibits a sharp
endothermic peak (absent in the complexes 1 and 2)a t
183◦C. An examination of the TG curves of the complexes
indicates that decomposition runs in three steps at 105–
115◦C, 115–185◦C, and 185–360◦C. Afterwards the com-
plexes decompose continuously up to 700◦C. The ﬁrst and
second steps are suggested to represent expulsion of two
methyl groups, calc. (7.2%, 5.0%, 7.8%, and 4.2% for the
complexes1,2,3,and4,resp.),found(7.7%,5.4%,8.2%and
4.4% for complexes 1, 2, 3, and 4, resp.). In the second step,
decomposition of ligand moiety was observed as calc. (64%,
78.1%, 42.0%, and 81.6%), found (64.3%, 78.7%, 42.3%,
and 82.0%), for complexes 1–4, respectively. Third stage of
pyrolysis corresponds to 21.3%, 19.8%, 12.9% and 16.5%
weight losses for the complexes 1, 2, 3, and 4, respectively,
and was consistent with the expulsion of phenanthroline
moiety leaving behind metal oxide as the end-product.
The DSC plots are consistent with the decomposition
patternof the ligand(L1) andits complexes (1and 2).Apeak
observed at 184◦C indicates the pyrolysis of the ligand as an
exothermic process. However, there is no well-deﬁned peak
for the formation of metal oxide as the end product.
Based on these, the following structures are assigned to
the prepared complexes (Figure 2).
8.Biological Results
8.1. Antimicrobial Activity. In vitro antimicrobial activity
of the ligands and their corresponding organotin complexes
was tested by the paper disc diﬀusion method [24, 25]
at 200μg/mL concentration in DMF. The bacteria were
subcultured in agar medium, and the Petri dishes were
incubated for 24h at 37◦C. Standard antibacterial drug
(Chloramphenicol) was also screened under similar condi-
tions for comparison. The fungi were subcultured in potato
dextrose agar medium and the Petri dishes were incubated
for 72hs at 37◦C. Standard antifungal drug (Griseofulvin)6 Bioinorganic Chemistry and Applications
Table 2: Infrared spectral data of the ligands and their organotin(IV) complexes.
ν/cm−1
compound ν(C=O) ν(O–H) ν(C=N) ν(M–N) ν(M–O) ν(–N–SO2)
L1 1768 and 1725 3384 1618 — — —
1 1676 — — 512 384 —
2 1650 and 1725 — 1617 516 417 —
L2 — 3423 1652 — — 941
3 — — — 480 and 461 403 891
4 — 3423 1658 415 — 941
Table 3: 1H-NMR data of the ligands and organotin(IV) com-
plexes.
compound HC=N –OH Ar–H –NH Sn–CH3 O–CH3
L1 9.45 10.67 6.92–7.91 — — —
1 9.46 10.63 6.90–7.88 — — —
2 9.46 10.65 6.92–7.94 — — —
L2 9.77 10.26 6.01–7.95 11.24 — 3.84
3 9.77 10.28 6.01–7.93 11.30 1.03 3.84
4 9.75 10.26 6.01–7.95 — 1.03 3.82
was used for comparison. The wells were dug into the agar
media using a sterile metallic borer. Activity was determined
by measuring the diameter of the zone showing complete
inhibition (mm). Growth inhibition was compared with
the standard drugs (positive drug). Negative controls were
prepared using the same solvent, DMF, employed to dissolve
the test compounds (no activity against any microbial
strains). By the observation of zones of inhibition, it was
concludedthattheorganotincomplexesaremoreactivethan
free ligands, which indicates that the metallation increases
antimicrobial activity. The above studies reveal that the
organotin complexes synthesized in the present work are
highly active against all the selected microorganisms. The
results reported in Table 4 reveal that all the organotin
complexes are particularly active against bacteria E. coli,
S. aureus, R. solanacearum and against fungi, namely,
A. niger and A. solani. The complexes showed moderate
activity against other selected species of microorganisms.
8.2. DNA Binding Experiments. DNA binding experiments
for the complexes were performed in Tris-HCl/NaCl buﬀer
(5mM Tris-HCl, 5mM NaCl, pH 7.2) using aqueous
solution of the complexes. Calf-thymus DNA (CT-DNA) in
Tris-HCl buﬀer gave a ratio of the UV absorbance at 260
and 280nm of ca 1.9:1 indicating the purity of DNA which
is apparently free from proteins [26]. The concentration
of DNA was calculated from its absorption intensity at
260nm with known molar absorption coeﬃcient value of
6600cm−1. UV-Vis absorption titration experiments were
performed by varying the concentration of CT-DNA keeping
the metal complex concentration constant (50μM). Samples
were allowed to get equilibrated to bind suﬃciently to CT-
DNA before recording each spectrum. From the observed
data, the intrinsic binding constant, Kb was calculated by
using the following [27]:
[DNA] 
εa −εf
 =
[DNA] 
εb −εf
 +
1
Kb

εa −εf

,( 1 )
where εa, εf, εb are the apparent, free, and bound metal
complex extinction coeﬃcients. A plot of [DNA]/(εa − εf)
versus [DNA] gave a slope of 1/(εb − εf)a n da“ y” intercept
equal to 1/Kb (εa − εf), where Kb is the ratio of the slope to
the y intercept.
Absorption spectra of the complexes 1 and 3 in the
absence and in the presence of CT-DNA are shown in
Figures 4 and 5. With increasing concentration of CT-
DNA, the absorption bands were aﬀected and show minor
bathochromic shift of the spectral band of ∼4nm with sig-
niﬁcant hypochromicity, suggesting mainly groove binding
property of complexes to the double-stranded DNA [28].
Bothligandsexhibitcomparativelylessbindingpropensityto
theCT-DNA.TheDNAbindingpropertyofcomplex 1could
beduetothepresenceofindolinesystemandthatofcomplex
3 could be due to the presence of extended pyrimidine ring
system.
8.3. Viscosity Measurements. The nature of binding of the
complexes 1 and 3 to the CT-DNA was further investigated
by viscometric studies. Viscosity measurements were carried
out in buﬀer solution (pH 7.2) using an Ubbelodhe vis-
cometer at room temperature. Flow time was measured by
handwithdigitalstopwatch,eachsamplewasmeasuredthree
times, and the average ﬂow time was calculated. A signiﬁcant
increase in the viscosity of DNA on addition of complex
results due to the intercalation which leads to the separation
among the DNA bases in the increase in the eﬀective size
in DNA which could be the reason for the increase in the
viscosity [29]. Plot of (η/ηo)1/3 versus [complex]/[DNA]
gives a measure of the viscosity changes (Figure 6). A gradual
increase in the relative viscosity was observed on addition of
the complexes 1 and 3 to DNA solution suggesting mainly
groove binding nature of the complexes.
8.4.DNACleavage. TheDNAcleavageexperimentsofsuper-
coiled (SC) pUC19 DNA by the organotin(IV) complexes
was studied by agarose gel electrophoresis. DMF solutions
of the complexes were placed in clean eppendrrof tubes, and
1μgofpUC19DNAwasadded. ThecontentswereincubatedBioinorganic Chemistry and Applications 7
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Figure 5: The plot of [DNA]/(εa −εf) versus [DNA] for the titration of DNA with the complexes (a) 1 and (b) 3.
for 30min at 37◦C and loaded on 0.8% agarose gel after
mixing with 5mL of loading buﬀer [0.25% bromophenol
blue+0.25%xylenecyanol+30%glycerol(2μL)+sterilized
distilled water], and the solution was ﬁnally loaded on
0.8% agarose gel containing 1.0μg/mL ethidium bromide
(EB). Electrophoresis was performed at constant voltage
(70V) until the bromophenol blue reached to the 3/4th
of the gel. The bands were visualized by UV light and
photographed. The extent of cleavage of SC DNA was
determined by the ability of complex to form open circular
(OC)ornickedcircular(NC)DNAfromitssupercoiled(SC)
form. The extent of DNA cleavage, observed by agarose gel8 Bioinorganic Chemistry and Applications
Table 4: Antimicrobial activity of Schiﬀ bases and their corresponding organotin(IV) complexes.
Compound
Antibacterial activity Antifungal activity
Zone of inhibition (in mm)∗
B. subtilis E. coli S. aureus R. solanacearum X. vesicatoria A. niger A. ﬂavus F. oxysporum A. solani
L1 05 04 06 08 04 07 05 04 08
1 20 23 21 27 22 24 21 19 22
2 17 24 19 23 19 22 17 18 21
L2 09 06 05 11 04 09 08 05 10
3 19 11 20 26 21 23 20 21 23
4 14 12 17 21 15 21 15 17 19
Chloramphenicol 29 26 25 32 35 — — — —
Griseofulvin — — — — — 27 23 26 25
∗Average of three replicates.
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Figure 6: Eﬀect of increasing amounts of complexes (1 and 3)a n d
ligands on the relative viscosity of CT-DNA at 25 ± 0.1◦C.
electrophoresis, gives the order 1>3 4>2 (Figures 3(a) and
3(b)).
9. Conclusion
Inconclusion,wehavesynthesizedtwoimportantSchiﬀbase
ligands and their organotin(IV) complexes. The structures
of synthesized ligands and complexes were conﬁrmed by
the analytical, spectral, and thermal studies. Antimicrobial
results reveal that activity enhances upon coordination,
which were compared with standard drugs. All the organotin
complexes are particularly active against bacteria E. coli, S.
aureus, R. solanacearum and against fungi, namely, A. niger
and A. solani. The interaction of complexes 1 and 3 with
CT-DNA has been investigated with UV spectroscopic, and
viscosity studies have shown that the complexes are simple
groove binders to the CT-DNA. The photocleavage studies of
complexes 1 and 3 were performed, and results reveal that
both the complexes are capable of promoting the cleavage of
plasmid DNA under physiological conditions.
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